Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

More vellus hairs in frontal scalp indicate early female pattern hair loss.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

White and yellow dots indicate severe female hair loss in dark skin.

Blocking interferon-gamma might help treat various autoimmune diseases.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Erdr1 could be a new marker for diagnosing hair loss.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

The document concludes that understanding hair loss and its psychological impact is crucial for physicians to provide effective counseling and treatment to patients.

Adequate steroid treatment needed to limit bone loss in PMR patients.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.